Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxime Gualtieri

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Frontiers in Microbiology|January 11, 2020
From Worms to Drug Candidate: The Story of Odilorhabdins, a New Class of Antimicrobial AgentsEmilie Racine, Maxime Gualtieri
The Journal of Antibiotics|April 18, 2009
Identification of a new antimicrobial lysine-rich cyclolipopeptide family from Xenorhabdus nematophilaMaxime Gualtieri, André Aumelas, Jacques-Olivier Thaler
International Journal of Antimicrobial Agents|August 18, 2009
Frequency and characterisation of spontaneous lipiarmycin-resistant Enterococcus faecalis mutants selected in vitroMaxime Gualtieri, Audrey Tupin, Konstantin Brodolin, et al.
Future Microbiology|March 5, 2009
Myxopyronin: a punch in the jaws of bacterial RNA polymeraseAudrey Tupin, Maxime Gualtieri, Konstantin Brodolin, et al.
The EMBO Journal|June 22, 2010
The transcription inhibitor lipiarmycin blocks DNA fitting into the RNA polymerase catalytic siteAudrey Tupin, Maxime Gualtieri, Jean-Paul Leonetti, et al.
Antimicrobial Agents and Chemotherapy|July 4, 2007
In vitro activities of different inhibitors of bacterial transcription against Staphylococcus epidermidis biofilmPhilippe Villain-Guillot, Maxime Gualtieri, Lionel Bastide, et al.
Drug Discovery Today|March 3, 2007
Progress in targeting bacterial transcriptionPhilippe Villain-Guillot, Lionel Bastide, Maxime Gualtieri, et al.
Genome Announcements|March 15, 2014
Draft Genome Sequence and Annotation of the Entomopathogenic Bacterium Xenorhabdus szentirmaii Strain DSM16338Maxime Gualtieri, Jean-Claude Ogier, Sylvie Pagès, et al.
Antimicrobial Agents and Chemotherapy|December 27, 2005
Mutation in the Bacillus subtilis RNA polymerase beta' subunit confers resistance to lipiarmycinMaxime Gualtieri, Philippe Villain-Guillot, Jaqueline Latouche, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2009
Use of a surface plasmon resonance method to investigate antibiotic and plasma protein interactionsFrançoise Banères-Roquet, Maxime Gualtieri, Philippe Villain-Guillot, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Frontiers in Microbiology|January 11, 2020
From Worms to Drug Candidate: The Story of Odilorhabdins, a New Class of Antimicrobial AgentsEmilie Racine, Maxime Gualtieri
The Journal of Antibiotics|April 18, 2009
Identification of a new antimicrobial lysine-rich cyclolipopeptide family from Xenorhabdus nematophilaMaxime Gualtieri, André Aumelas, Jacques-Olivier Thaler
International Journal of Antimicrobial Agents|August 18, 2009
Frequency and characterisation of spontaneous lipiarmycin-resistant Enterococcus faecalis mutants selected in vitroMaxime Gualtieri, Audrey Tupin, Konstantin Brodolin, et al.
Future Microbiology|March 5, 2009
Myxopyronin: a punch in the jaws of bacterial RNA polymeraseAudrey Tupin, Maxime Gualtieri, Konstantin Brodolin, et al.
The EMBO Journal|June 22, 2010
The transcription inhibitor lipiarmycin blocks DNA fitting into the RNA polymerase catalytic siteAudrey Tupin, Maxime Gualtieri, Jean-Paul Leonetti, et al.
Antimicrobial Agents and Chemotherapy|July 4, 2007
In vitro activities of different inhibitors of bacterial transcription against Staphylococcus epidermidis biofilmPhilippe Villain-Guillot, Maxime Gualtieri, Lionel Bastide, et al.
Drug Discovery Today|March 3, 2007
Progress in targeting bacterial transcriptionPhilippe Villain-Guillot, Lionel Bastide, Maxime Gualtieri, et al.
Genome Announcements|March 15, 2014
Draft Genome Sequence and Annotation of the Entomopathogenic Bacterium Xenorhabdus szentirmaii Strain DSM16338Maxime Gualtieri, Jean-Claude Ogier, Sylvie Pagès, et al.
Antimicrobial Agents and Chemotherapy|December 27, 2005
Mutation in the Bacillus subtilis RNA polymerase beta' subunit confers resistance to lipiarmycinMaxime Gualtieri, Philippe Villain-Guillot, Jaqueline Latouche, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2009
Use of a surface plasmon resonance method to investigate antibiotic and plasma protein interactionsFrançoise Banères-Roquet, Maxime Gualtieri, Philippe Villain-Guillot, et al.
Pageof 3